Collegium Pharmaceutical Share Price Rises But Trails Market Gains Despite Strong Revenue Growth
-
Collegium Pharmaceutical share price rose 34% over 5 years, below market return. Share price up 22% over past year.
-
Company made a loss in last 12 months, so shareholders focused on strong revenue growth of 14% per year over 5 years.
-
Annual gain of 6% over 5 years better than nothing, but below market. Share price may have been over optimistic.
-
Trading at big discount to estimated fair value. Earnings forecast to grow 41% per year.
-
No major risks detected. Earnings grown 27% per year over past 5 years.